Pembrolizumab versus cetuximab concurrent with radiotherapy in patients with locally advanced squamous cell carcinoma of head and neck unfit for cisplatin (GORTEC 2015-01 PembroRad): a multicenter, randomized, phase II trial.
Ann Oncol
; 34(1): 101-110, 2023 01.
Article
in En
| MEDLINE
| ID: mdl-36522816
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Chemoradiotherapy
/
Squamous Cell Carcinoma of Head and Neck
/
Head and Neck Neoplasms
Type of study:
Clinical_trials
Limits:
Aged
/
Humans
/
Middle aged
Language:
En
Journal:
Ann Oncol
Journal subject:
NEOPLASIAS
Year:
2023
Type:
Article
Affiliation country:
France